Headline News about Novartis Ag ADR![]() ![]() ![]()
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Via Benzinga
![]()
How Is The Market Feeling About Novartis?
November 10, 2023
Via Benzinga
![]() ![]() ![]()
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
October 24, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]() ![]()
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More
October 24, 2023
Via Benzinga
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|